| Formulary Chapter 26: A5 - Wound managment products and elasticated garments - Full Chapter
|
| Chapter Links... |
 CCG Woundcare formulary |
| CityCare Wound Care Formulary |
| NICE therapeutic topic: Wound care products |
 Wound Care: NUH Woundcare Product Formulary Booklet and Dressing Supplier |
| Wound care: SFH first line dressings table |
| Wound care: SFH Full dressings formulary |
| Wound care: SFH second line dressings table |
| Details... |
| A5.01.02 |
Absorbent dressings |
|
|
| A5.01.02 |
For lightly exuding wounds |
|
|
Softpore
|
Formulary
|
In secondary care ordered via NHS Supplies by each ward. Not available from pharmacy.
- Available as 6x7cm, 10x10cm, 10x15cm, 10x20cm, 10x25cm, 10x30cm, 10x35cm
- Only 6x7cm and 10x10cm sizes routinely available at SFH
|
|
|
Telfa
|
Formulary
|
In secondary care, ordered via NHS Supplies by each ward. Not available from pharmacy.
Available as 5x 7.5cm, 10x 7.5cm, 20x 7.5cm
|
|
|
Insight Tracheostomy Dressing
|
Formulary
|
Available as 80x80mm
Not available on FP10- for FP10 options see Permafoam and Trachi-Dress
|
|
|
| A5.01.02 |
For moderately to heavily exuding wounds |
|
|
Eclypse Non-adherent
|
Formulary
|
- Replaced by Zetuvit E as per SFH dressings formulary.
On specialist advice; second line choice as per SFH dressings formulary.
At SFH, wards to order direct from NHS Supplies
At NUH, can be ordered from Pharmacy if advised by tissue viability
- Available as 15x15cm, 20x30cm, 60x40cm and 60x70cm boot (for use in exceptional circumstances only)
|
|
|
Trachi-Dress
(Tracheostomy dressing)
|
Formulary
|
Available as 60x82mm and 80x100mm
|
|
|
Zetuvit E Sterile
|
Formulary
|
At NUH wards to order direct from NHS Supplies. Not routinely available at SFH
- Available as 10x10cm, 10x20cm, 20x20cm and 20x40cm
|
|
|
| A5.01.02 |
For heavily exuding wounds |
|
|
| .... |
| Non Formulary Items |
Mesorb
|
Non Formulary
|
Previously contained in the South's Wound Care Formulary |
|
|
Release
|
Non Formulary
|
Previously available in the South's Wound Care Formulary. Now replaced by Telfa |
|
|
Skintact
|
Non Formulary
|
Previously contained in the North's Wound Care Formulary. Now replaced by Telfa. |
|
|
| |
Key |
|
|
|
|
Cytotoxic Drug
|
|
|
Controlled Drug
|
|
High Cost Medicine
|
|
Cancer Drugs Fund
|
|
NHS England |
|
Homecare |
|
CCG |
|
Traffic Light Status Information
| Status |
Description |
|
Grey / Non-Formulary: Medicines, which the Nottinghamshire APC has actively reviewed and does not recommend for use at present due to limited clinical and/or cost effective data.
Grey / Non-Formulary (undergoing assessment): Work is ongoing and will be reviewed at a future APC meeting.
Grey / Non-Formulary (no formal assessment): APC has not formally reviewed this medicine or indication because it had never been requested for formulary inclusion. Often used for drugs new to market.
|
|
Medicines which should normally be prescribed by specialists only. eg hospital only.
For patients already receiving prescriptions in primary care - continue. No new patients to receive prescriptions in primary care.
|
|
Medicines that should be initiated by a specialist and prescribed by primary care prescribers only under a shared care protocol, once the patient has been stabilised.
Prior agreement must be obtained by the specialist from the primary care provider before prescribing responsibility is transferred. The shared care protocol must have been agreed by the relevant secondary care trust Drugs and Therapeutics Committee(s) (DTC) and approved by the Nottinghamshire APC.
|
|
Medicines suitable to be prescribed in primary care / general practice after specialist* recommendation or initiation.
A supporting prescribing guideline may be requested which must have been agreed by the relevant secondary care trust DTCs and approved by the Nottinghamshire APC.
*Specialist is defined by the APC as a clinician who has undertaken an appropriate formal qualification or recognised training programme within the described area of practice
|
|
Primary care/ non specialist may initiate as per APC guideline.
The supporting prescribing guideline must have been agreed by the relevant secondary care trust D&TC(s) and approved by the Nottinghamshire APC.
|
|
Medicines suitable for routine use within primary care.
Can be initiated within primary care within their licensed indication, in accordance with nationally recognised formularies, for example the BNF, BNF for Children, Medicines for Children or Palliative Care Formulary. Primary care prescribers take full responsibility for prescribing. |
|
|
|
|
|
